Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Genprex ( (GNPX) ) has shared an update.
On January 7, 2026, Genprex, Inc. announced that it had regained compliance with Nasdaq’s minimum stockholders’ equity requirement of $2.5 million under Listing Rule 5550(b)(1), resolving a deficiency first flagged by Nasdaq in an August 19, 2025 notice. The company will remain under mandatory panel monitoring through January 7, 2027, and any renewed failure to meet the equity threshold during this period would trigger an automatic delisting determination without a further cure period, leaving Genprex to rely on a new hearing process and exposing shareholders to the heightened risk of the company’s securities being removed from the Nasdaq exchange.
More about Genprex
Average Trading Volume: 807,246
Technical Sentiment Signal: Sell
Current Market Cap: $4.38M
For detailed information about GNPX stock, go to TipRanks’ Stock Analysis page.